GPR171 and graft versus host disease: In addition, GSEA analysis showed that DIRAS3, GPR171, and RAC2 are involved in signaling pathways such as ECM–receptor interaction, complement and cohesion cascades, adhesion plaques, allograft rejection, autoimmune thyroid disease, graft-versus-host disease, and cell adhesion molecules.